Cerebrospinal fluid of Alzheimer's disease and dementia with Lewy bodies patients enhances α-synuclein fibril formation in vitro

被引:10
作者
Ono, Kenjiro
Noguchi-Shinohara, Moeko
Yoshita, Mitsuhiro
Naiki, Hironobu
Yamada, Masahito [1 ]
机构
[1] Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol Aging, Kanazawa, Ishikawa 9208640, Japan
[2] Univ Fukui, Fac Med Sci, Dept Pathol Sci, Div Mol Pathol, Fukui 9101193, Japan
关键词
Alzheimer's disease; dementia with Lewy bodies; alpha-synuclein; alpha-synuclein fibril; thioflavin S; electron microscopy;
D O I
10.1016/j.expneurol.2006.08.012
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Deposition of alpha-synuclein (alpha S) aggregates inside brain cells is a pathological hallmark of several neurodegenerative diseases, including Parkinson's disease (PD), and dementia with Lewy bodies (DLB). Recently, extracellular aS was detected in cerebrospinat fluid (CSF) and plasma of humans. We investigated whether CSF influences alpha S aggregation in vitro using fluorescence spectroscopy with thioflavin S and electron microscopy. We found that CSF obtained from Alzheimer's disease (AD) and DLB patients enhanced the alpha S fibril formation compared with tauopathy and non-central nervous system disease. Thus, CSF of AD and DLB characterized by aggregation of A beta or alpha S might promote f alpha S formation. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:579 / 583
页数:5
相关论文
共 26 条
  • [1] Full length α-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects
    Borghi, R
    Marchese, R
    Negro, A
    Marinelli, L
    Forloni, G
    Zaccheo, D
    Abbruzzese, G
    Tabaton, M
    [J]. NEUROSCIENCE LETTERS, 2000, 287 (01) : 65 - 67
  • [2] Staging of brain pathology related to sporadic Parkinson's disease
    Braak, H
    Del Tredici, K
    Rüb, U
    de Vos, RAI
    Steur, ENHJ
    Braak, E
    [J]. NEUROBIOLOGY OF AGING, 2003, 24 (02) : 197 - 211
  • [3] Protofibrils, pores, fibrils, and neurodegeneration: Separating the responsible protein aggregates from the innocent bystanders
    Caughey, B
    Lansbury, PT
    [J]. ANNUAL REVIEW OF NEUROSCIENCE, 2003, 26 : 267 - 298
  • [4] α-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma
    El-Agnaf, OMA
    Salem, SA
    Paleologou, KE
    Cooper, LJ
    Fullwood, NJ
    Gibson, MJ
    Curran, MD
    Court, JA
    Mann, DMA
    Ikeda, S
    Cookson, MR
    Hardy, J
    Allsop, D
    [J]. FASEB JOURNAL, 2003, 17 (11) : 1945 - +
  • [5] Detection of oligomeric forms of α-synuclein protein in human plasma as a potential biomarker for Parkinson's disease
    El-Agnaf, Omar M. A.
    Salem, Sultan A.
    Paleologou, Katerina E.
    Curran, Martin D.
    Gibson, Mark J.
    Court, Jennifer A.
    Schlossmacher, Michael G.
    Allsop, David
    [J]. FASEB JOURNAL, 2006, 20 (03) : 419 - 425
  • [6] FRITZ RB, 1972, J IMMUNOL, V108, P108
  • [7] FUJITA Y, 1984, CHEM PHARM BULL, V32, P4161
  • [8] Is there a cause-and-effect relationship between α-synuclein fibrillization and Parkinson's disease?
    Goldberg, MS
    Lansbury, PT
    [J]. NATURE CELL BIOLOGY, 2000, 2 (07) : E115 - E119
  • [9] A NEW CLINICAL-SCALE FOR THE STAGING OF DEMENTIA
    HUGHES, CP
    BERG, L
    DANZIGER, WL
    COBEN, LA
    MARTIN, RL
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1982, 140 (JUN) : 566 - 572
  • [10] IDENTIFICATION OF 2 DISTINCT SYNUCLEINS FROM HUMAN BRAIN
    JAKES, R
    SPILLANTINI, MG
    GOEDERT, M
    [J]. FEBS LETTERS, 1994, 345 (01) : 27 - 32